Off-label drugs [microform] : reimbursement policies constrain physicians in their choice of cancer therapies : report to the Chairman, Committee on Labor and Human Resources, U.S. Senate / United States General Accounting Office

Request this item

Request this item to view in the Library’s reading room.

Loading...